title: Danoprevir pharmacokinetic/viral kinetic model for treating chronic HCV - some considerations.
authors.affiliation: Suramus Bio, Drug Development, J.P. Nagar I Phase, Bangalore, India.
authors.forename: Nuggehally R
authors.initials: NR
authors.lastname: Srinivas
mesh_terms: D000998:Antiviral Agents / Q000493:pharmacokinetics*; D003521:Cyclopropanes; D006526:Hepatitis C / Q000378:metabolism*; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D054833:Isoindoles; D007769:Lactams / Q000493:pharmacokinetics* / Q000627:therapeutic use; D047029:Lactams, Macrocyclic; D008954:Models, Biological; D011392:Proline / Q000031:analogs & derivatives; D013449:Sulfonamides / Q000493:pharmacokinetics* / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D003521:Cyclopropanes; D054833:Isoindoles; D007769:Lactams; D047029:Lactams, Macrocyclic; D013449:Sulfonamides; C553752:danoprevir; D011392:Proline